Schwarze-Taufiq T, Pranoto I, Hui K, Kinoshita C, Yu O, Crane P
Alzheimers Dement (N Y). 2025; 11(1):e70040.
PMID: 39911736
PMC: 11795422.
DOI: 10.1002/trc2.70040.
Ahmadi E, Pourmotabbed A, Aghaz N, Nedaei S, Veisi M, Salimi Z
Res Pharm Sci. 2024; 19(5):509-519.
PMID: 39691296
PMC: 11648346.
DOI: 10.4103/RPS.RPS_94_23.
Remali J, Aizat W
Heliyon. 2024; 10(20):e38986.
PMID: 39640650
PMC: 11620067.
DOI: 10.1016/j.heliyon.2024.e38986.
Hosseini K, Cediel-Ulloa A, Al-Sabri M, Forsby A, Fredriksson R
Pharmaceuticals (Basel). 2024; 17(10).
PMID: 39459031
PMC: 11510426.
DOI: 10.3390/ph17101392.
Villafranco J, Martinez-Ramirez G, Magana-Maldonado R, Gonzalez-Ruvalcaba A, Lopez-Ornelas A, Velasco I
Front Psychiatry. 2024; 15:1470642.
PMID: 39444629
PMC: 11496182.
DOI: 10.3389/fpsyt.2024.1470642.
Citalopram exposure of hESCs during neuronal differentiation identifies dysregulated genes involved in neurodevelopment and depression.
Spildrejorde M, Leithaug M, Samara A, Aass H, Sharma A, Acharya G
Front Cell Dev Biol. 2024; 12:1428538.
PMID: 39055655
PMC: 11269147.
DOI: 10.3389/fcell.2024.1428538.
Exploring mood disorders and treatment options using human stem cells.
Hudock A, Leal Z, Sharma A, Mei A, Santos R, Marchetto M
Genet Mol Biol. 2024; 47Suppl 1(Suppl 1):e20230305.
PMID: 38954533
PMC: 11223183.
DOI: 10.1590/1678-4685-GMB-2023-0305.
Relationships of depression and antidepressant use with epigenetic age acceleration and all-cause mortality among postmenopausal women.
Beydoun M, Beydoun H, Ashe J, Georgescu M, Horvath S, Lu A
Aging (Albany NY). 2024; 16(10):8446-8471.
PMID: 38809417
PMC: 11164525.
DOI: 10.18632/aging.205868.
Depressive symptoms and antidepressant use in relation to white blood cell count among postmenopausal women from the Women's Health Initiative.
Beydoun H, Beydoun M, Wassertheil-Smoller S, Saquib N, Manson J, Snetselaar L
Transl Psychiatry. 2024; 14(1):157.
PMID: 38514652
PMC: 10958010.
DOI: 10.1038/s41398-024-02872-5.
Brain organoids and organoid intelligence from ethical, legal, and social points of view.
Hartung T, Pantoja I, Smirnova L
Front Artif Intell. 2024; 6:1307613.
PMID: 38249793
PMC: 10796793.
DOI: 10.3389/frai.2023.1307613.
Novel Strategy to Assess the Neurotoxicity of Organic Solvents Such as Glycol Ethers: Protocol for Combining In Vitro and In Silico Methods With Human-Controlled Exposure Experiments.
Hopf N, Suter-Dick L, Huwyler J, Borgatta M, Hegg L, Pamies D
JMIR Res Protoc. 2024; 13:e50300.
PMID: 38236630
PMC: 10835597.
DOI: 10.2196/50300.
Blood extracellular vesicles carrying brain-specific mRNAs are potential biomarkers for detecting gene expression changes in the female brain.
Smirnova L, Modafferi S, Schlett C, Osborne L, Payne J, Sabunciyan S
Mol Psychiatry. 2024; 29(4):962-973.
PMID: 38212371
DOI: 10.1038/s41380-023-02384-6.
Integrating distribution kinetics and toxicodynamics to assess repeat dose neurotoxicity using human BrainSpheres: a case study on amiodarone.
Nunes C, Proenca S, Ambrosini G, Pamies D, Thomas A, Kramer N
Front Pharmacol. 2023; 14:1248882.
PMID: 37745076
PMC: 10512064.
DOI: 10.3389/fphar.2023.1248882.
Advances in the knowledge and therapeutics of schizophrenia, major depression disorder, and bipolar disorder from human brain organoid research.
Villanueva R
Front Psychiatry. 2023; 14:1178494.
PMID: 37502814
PMC: 10368988.
DOI: 10.3389/fpsyt.2023.1178494.
Molecular and Functional Characterization of Different BrainSphere Models for Use in Neurotoxicity Testing on Microelectrode Arrays.
Hartmann J, Henschel N, Bartmann K, Donmez A, Brockerhoff G, Koch K
Cells. 2023; 12(9).
PMID: 37174670
PMC: 10177384.
DOI: 10.3390/cells12091270.
Human brain microphysiological systems in the study of neuroinfectious disorders.
Barreras P, Pamies D, Hartung T, Pardo C
Exp Neurol. 2023; 365:114409.
PMID: 37061175
PMC: 10205672.
DOI: 10.1016/j.expneurol.2023.114409.
Assessment of neurotransmitter release in human iPSC-derived neuronal/glial cells: a missing in vitro assay for regulatory developmental neurotoxicity testing.
Cervetto C, Pistollato F, Amato S, Mendoza-de Gyves E, Bal-Price A, Maura G
Reprod Toxicol. 2023; 117:108358.
PMID: 36863571
PMC: 10112275.
DOI: 10.1016/j.reprotox.2023.108358.
Oligodendrogenesis and myelination tracing in a CRISPR/Cas9-engineered brain microphysiological system.
Romero J, Berlinicke C, Chow S, Duan Y, Wang Y, Chamling X
Front Cell Neurosci. 2023; 16:1094291.
PMID: 36744062
PMC: 9893511.
DOI: 10.3389/fncel.2022.1094291.
Human-Based New Approach Methodologies in Developmental Toxicity Testing: A Step Ahead from the State of the Art with a Feto-Placental Organ-on-Chip Platform.
Luconi M, Sogorb M, Markert U, Benfenati E, May T, Wolbank S
Int J Environ Res Public Health. 2022; 19(23).
PMID: 36497907
PMC: 9737555.
DOI: 10.3390/ijerph192315828.
Neuronal differentiation pathways and compound-induced developmental neurotoxicity in the human neural progenitor cell test (hNPT) revealed by RNA-seq.
De Leeuw V, van Oostrom C, Wackers P, Pennings J, Hodemaekers H, Piersma A
Chemosphere. 2022; 304:135298.
PMID: 35700809
PMC: 9247748.
DOI: 10.1016/j.chemosphere.2022.135298.